Philip D. Schneider
- Surgery top 5%
- Hepatology top 1%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Epidemiology top 10%
- Co-authors
- Paul H. SugarbakerAlfred E. ChangMary CulnaneSeth M. SteinbergColleen SimpsonDavid A. AugustJames E. GoodnightSteven W. Merrell
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (9 papers)Sarcoma Diagnosis and Treatment (6 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers)
- Cited by
- HepatologyOncologySurgery
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Philip D. Schneider
52 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Surgery 997
- Hepatology 829
- Oncology 732
- Pulmonary and Respiratory Medicine 563
- Epidemiology 348
Countries citing papers authored by Philip D. Schneider
This map shows the geographic impact of Philip D. Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip D. Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip D. Schneider more than expected).
Fields of papers citing papers by Philip D. Schneider
This network shows the impact of papers produced by Philip D. Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip D. Schneider. The network helps show where Philip D. Schneider may publish in the future.
Co-authorship network of co-authors of Philip D. Schneider
This figure shows the co-authorship network connecting the top 25 collaborators of Philip D. Schneider. A scholar is included among the top collaborators of Philip D. Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip D. Schneider. Philip D. Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 75 | |
| 2 | 41 | |
| 3 | 53 | |
| 4 | 22 | |
| 5 | 54 | |
| 6 | 20 | |
| 7 | 64 | |
| 8 | 22 | |
| 9 | 9 | |
| 10 | 62 | |
| 11 | 23 | |
| 12 | 2 | |
| 13 | 14 | |
| 14 | 22 | |
| 15 | 18 | |
| 16 | 19 | |
| 17 | 13 | |
| 18 | 24 | |
| 19 | Retarding Novikoff tumor growth by altering host rat cholesterol metabolism. | 8 |
| 20 | The effect of selective visceral caval shunt on plasma lipids and cholesterol dynamics. | 7 |
About Philip D. Schneider
Philip D. Schneider is a scholar working on Hepatology, Surgery and Pulmonary and Respiratory Medicine, having authored 54 papers that have together received 2.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Sarcoma Diagnosis and Treatment (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). The work is most often cited by research in Hepatology (829 citations), Oncology (732 citations) and Surgery (997 citations). Philip D. Schneider has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Paul H. Sugarbaker, Alfred E. Chang, Mary Culnane, Seth M. Steinberg, Colleen Simpson, David A. August, James E. Goodnight, Steven W. Merrell, Vijay P. Khatri and Richard J. Bold. Their work appears in journals such as Journal of Biological Chemistry, American Journal of Clinical Nutrition and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.